FDA Approves First Subcutaneous Infliximab for IBD
October 23, 2023 : Celltrion USA has announced the U.S. Food and Drug Administration (FDA) approval of ZYMFENTRA® (infliximab-dyyb), the first and only subcutaneous infliximab, for the treatment of people with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis.
Kaiser Permanente and Union Reach Tentative Deal After Largest US Healthcare Strike
October 20, 2023 : Kaiser Permanente and the Coalition of Kaiser Permanente Unions (CKPU) have reached a tentative agreement after the largest healthcare strike in US history. The strike, involving over 75,000 workers, lasted three days and ended on October 7, 2023.
Centhaquine to Enter US-FDA Approved Phase 3 Clinical Trial in US and Europe
October 20, 2023 : Centhaquine, a novel drug candidate for treating Alzheimer’s disease (AD), is set to enter a Phase 3 clinical trial in the US and Europe. The trial has been approved by the US Food and Drug Administration (FDA).
Study Finds Cocaine Upregulates Brain Channels That Promote Reinforcement
October 17, 2023 : A recent study published in Molecular Psychiatry found that chronic cocaine exposure upregulates hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in ventral tegmental area (VTA) dopamine neurons. This upregulation of HCN channels promotes cocaine reinforcement, or the motivation to seek and consume cocaine.
Swedish Woman With Bionic Hand Regains 80% Function and Sense of Touch
October 17, 2023 : A Swedish woman who lost her hand in a boating accident has regained 80% of its function and sense of touch thanks to a bionic prosthetic. The woman, who has chosen to remain anonymous, had the prosthetic implanted in her arm at the Sahlgrenska University Hospital in Gothenburg, Sweden, in 2020.
EMD Serono to Present Latest Oncology Research at ESMO 2023
October 16, 2023 : EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany, in the US and Canada, today announced that it will present 28 abstracts featuring the latest research on the company’s oncology portfolio addressing unmet needs across bladder, head and neck, lung, colorectal and other cancers at the European Society for Medical Oncology (ESMO) Congress 2023, which will be held virtually and in-person in Madrid, Spain from October 20 to 24.
Ketamine Clinics Offer New Hope for Patients with Severe Depression
October 13, 2023 : The biopharmaceutical industry has achieved remarkable productivity recently, approving 287 new medicines from 2017 to 2022. These include treatments for various diseases such as cancers, rare diseases, diabetes, obesity, and even Alzheimer’s. Moreover, the industry played a pivotal role in combatting the COVID-19 pandemic by developing vaccines and therapeutics. These achievements have positively impacted billions of people worldwide.
USA Health Names Deborah Browning, New CEO for Children’s & Women’s Hospital
October 11, 2023 : USA Health, the University of South Alabama’s academic medical center, has named Deborah Browning, MSN, RN, CENP, as the new chief executive officer of its Children’s & Women’s Hospital. Browning has been with the hospital since 2021, serving as chief nursing officer and interim administrator.
Philips Puts AI-Enhanced Point-of-Care Ultrasound Center-Stage in Emergency Medicine at ACEP 2023
October 11, 2023 : Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is putting AI-enhanced point-of-care ultrasound (POCUS) center-stage in emergency medicine at the American College of Emergency Physicians (ACEP) 2023 Annual Meeting in San Diego, California.
Flesh-eating Ulcer Spreads Further in Australia as Cases Rise
October 10, 2023 : Buruli ulcer, or Bairnsdale ulcer, is a flesh-eating ulcer caused by the bacterium Mycobacterium ulcerans. The disease is most common in tropical and subtropical regions but has been spreading to new areas in recent years.
